Keyphrases
Malignant Glioma
100%
Phase II Trial
100%
Temozolomide
100%
Radiation Therapy
100%
Arsenic Trioxide
100%
Anaplastic Glioma
33%
Phase I Trial
22%
Overall Survival
11%
Mechanism of Action
11%
Newly Diagnosed
11%
Adverse Events
11%
Best Response
11%
Arsenic
11%
Bilirubin
11%
Elevated Liver Enzymes
11%
Patient-completed
11%
Post-irradiation
11%
Historic Data
11%
Radiation-based Method
11%
MGMT Status
11%
MGMT Testing
11%
Medicine and Dentistry
Radiation Therapy
100%
Phase II Trials
100%
Glioblastoma
100%
Temozolomide
100%
Arsenic Trioxide
100%
Ganglioglioma
33%
Phase I Trials
22%
Magnetic Resonance Imaging
11%
Side Effect
11%
Bilirubin
11%
Overall Survival
11%
Adverse Event
11%
Elevated Transaminases
11%
Pharmacology, Toxicology and Pharmaceutical Science
Arsenous Acid
100%
Phase II Trials
100%
Arsenite
100%
Glioblastoma
100%
Temozolomide
100%
Phase I Trials
22%
Overall Survival
11%
Adverse Event
11%
Side Effect
11%
Bilirubin
11%
Hypertransaminasemia
11%